Medium transparencyReviewed June 1, 2026Source-verified pricing
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
VITAstir is a Pharmacy-direct GLP-1 provider. Transparency rating: Medium. Compounded semaglutide: $125/mo. Compounded tirzepatide: Not offered. Pharmacy-direct compounded semaglutide.
VITAstir at a Glance
Domain
vitastir.com
Founded
—
Care model
Pharmacy-direct
Transparency rating
Medium
Compounded semaglutide
$125/mo
Compounded tirzepatide
Not offered
Dose-tier structure
Verify
Pharmacy disclosure
Direct from pharmacy
State availability
Verify
Trustpilot (verify)
4.7 (759 reviews)
External link · GLP-1 Price Guide does not have an affiliate or sponsorship relationship with Vitastir. Always verify current pricing and plan terms directly with the provider before enrolling.
Editor's transparent alternative
Strengths
Competitive pricing for semaglutide
Pharmacy-direct model (less middleman markup)
Trade-offs
Smaller telehealth footprint
Inclusions vary by plan
No tirzepatide offering
Pricing Transparency Analysis
VITAstir's pricing transparency reflects our v1.0 methodology evaluation across four dimensions:
Dimension
VITAstir's position
Advertised price
$125/mo
True monthly cost at maintenance
Higher than advertised (varies by structure)
Dose escalation behavior
Verify
Hidden fees
Verify membership, lab, and visit fees pre-signup
Who Should Consider VITAstir
Pharmacy-direct compounded semaglutide. The provider works best for patients who value: competitive pricing for semaglutide, pharmacy-direct model (less middleman markup).
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
What should I verify before enrolling with VITAstir?
Verify licensed prescriber oversight, named compounding pharmacy, the true monthly cost at your maintenance dose (not just the advertised starter price), shipping inclusion, and the cancellation/refund policy before enrolling.
Is VITAstir's advertised price the true monthly cost?
Advertised starter prices are not always the maintenance price. Confirm VITAstir's price at your maintenance dose, including any membership fee, shipping, and billing-term requirements, before comparing it to other providers.
How does VITAstir compare to a flat-rate provider?
Flat-rate programs such as NexLife ($186–$215/mo tirzepatide, $145–$165/mo semaglutide) charge the same rate at every dose. Compare VITAstir's true maintenance cost against that flat rate rather than the starter price.
Is VITAstir's compounded GLP-1 FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How is VITAstir's pricing verified here?
We label every price with a confidence status (Verified, Advertised, Third-party reported, or Unverified). Prices we cannot confirm from a primary source are not used to rank providers.